Have a personal or library account? Click to login
Olfactory neuroblastoma: Up-to-date review and our experience Cover

Olfactory neuroblastoma: Up-to-date review and our experience

Open Access
|Jul 2023

References

  1. Duo GS, Feng JL, Zhang ZY, Wang LJ. Survival impact of postoperative radio-therapy in patients with olfactory neuroblastoma: 513 cases from the SEER database. Cancer Radiother. 2022;26(5):663-9. DOI: 10.1016/j.canrad.2021.12.006.
  2. Kumar R. Esthesioneuroblastoma: Multimodal management and review of literature. World J Clin Cases. 2015;3(9):774-8. DOI: 10.12998/wjcc.v3.i9.774.
  3. Abdelmeguid AS. Olfactory neuroblastoma. Curr Oncol Rep. 2018;20(1):7. DOI: 10.1007/s11912-018-0661-6.
  4. Fiani B, Quadri SA, Cathel A, Farooqui M, Ramachandran A, Siddiqi I, et al. Esthesioneuroblastoma: A comprehensive review of diagnosis, management, and current treatment options. World Neurosurg. 2019;126:194-211. DOI: 10.1016/j.wneu.2019.03.014.
  5. Modesto A, Blanchard P, Tao YG, Rives M, Janot F, Serrano E, et al. Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma. Oral Oncol. 2013;49(8):830-4. DOI: 10.1016/j.oraloncology.2013.04.013.
  6. Thompson LDR. Olfactory neuroblastoma. Head Neck Pathol. 2009;3(3):252-9. DOI: 10.1007/s12105-009-0125-2.
  7. Meyer C, Hamersley ERS, Manosalva RE, Torske K, McIntyre N, Mitchell A. Olfactory neuroblastoma with divergent differentiation: an unusual histologic finding in a rare tumor. Head Neck Pathol. 2017;11(4):531-6. DOI: 10.1007/ s12105-017-0781-6.
  8. Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer. 1976;37(3):1571-6. DOI: 10.1002/1097-0142(197603)37:3<1571::aid-cncr2820370347>3.0.co;2-I.
  9. Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery. 1993;32(5):706-14; discussion 714-5. DOI: 10.1227/00006123-199305000-00002.
  10. Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope. 1992;102(8):843-9. DOI: 10.1288/00005537-199208000-00001.
  11. Saade RE, Hanna EY, Bell D. Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system. Curr Oncol Rep. 2015;17(1):423. DOI: 10.1007/s11912-014-0423-z.
  12. Goshtasbi K, Abiri A, Abouzari M, Sahyouni R, Wang BY, Tajudeen BA, et al. Hyams grading as a predictor of metastasis and overall survival in esthesioneuroblastoma: a meta-analysis. Int Forum Allergy Rhinol. 2019;9(9):1054-62. DOI: 10.1002/alr.22373.
  13. Holmes M, Su SY, Bell D. Ectopic primary olfactory neuroblastoma of the maxillary sinus. Ann Diagn Pathol. 2016;22:45-48. DOI: 10.1016/j.anndiag-path.2016.04.001.
  14. Paul D, Bhardwaj S, Yadav G, Kaushal V. Aggressiveness of esthesioneuroblastoma: a rare case report and review of literature. Oncology in Clinical Practice. 2022;18(6):410-4. DOI: 10.5603/OCP.2022.0041.
  15. Dulguerov P, Allal A, Calcaterra T. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001;2(11):683-90. DOI: 10.1016/S1470-2045(01)00558-7.
  16. Abdelmeguid AS, Raza SM, Su SY, Kupferman M, Roberts D, DeMonte F, et al. Endoscopic resection of sinonasal malignancies. Head Neck. 2020;42(4):645-52. DOI: 10.1002/hed.26047.
  17. Gallia GL, Reh DD, Lane AP, Higgins TS, Koch W, Ishii M. Endoscopic resection of esthesioneuroblastoma. J Clin Neurosci. 2012;19(11):1478-82. DOI: 10.1016/j.jocn.2012.03.011.
  18. Eriksen JG, Bastholt L, Krogdahl AS, Hansen O, Joergensen KE. Esthesioneuroblastoma - what is the optimal treatment? Acta Oncol. 2000;39(2):231-5. DOI: 10.1080/028418600430833.
  19. Alami Z, Farhane FZ, Bouziane A, Mhirech S, Joutei SA, Hassani W, et al. Management of esthesioneuroblastoma: A retrospective study of 6 cases and literature review. Case Rep Oncol. 2022;15(1):176-86. DOI: 10.1159/000521736.
  20. Leonetti JP, Weishaar JR, Gannon D, Harmon GA, Block A, Anderson DE. Osteoradionecrosis of the skull base. J Neurooncol. 2020;150(3):477-82. DOI: 10.1007/s11060-020-03462-3.
  21. Jiang W, Mohamed ASR, Fuller CD, Kim BYS, Tang C, Gunn GB, et al. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol. 2016;6(4):241-7. DOI: 10.1016/j. prro.2015.10.023.
  22. Abdelmeguid AS, Bell D, Roberts D, Ferrarotto R, Phan J, Su SY, et al. Long-term outcomes of olfactory neuroblastoma: MD Anderson Cancer Center experience and review of the literature. Laryngoscope. 2022;132(2):290-7. DOI: 10.1002/lary.29732.
  23. Su SY, Bell D, Ferrarotto R, Phan J, Roberts D, Kupferman ME, et al. Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck. 2017;39(8):1671-9. DOI: 10.1002/hed.24822.
  24. De Bonnecaze G, Lepage B, Rimmer J, Al Hawat A, Vairel B, Serrano E, et al. Long-term carcinologic results of advanced esthesioneuroblastoma: a systematic review. Eur Arch Otorhinolaryngol. 2016;273(1):21-6. DOI: 10.1007/ s00405-014-3320-z.
  25. Ward PD, Heth JA, Thompson BG, Marentette LJ. Esthesloneuroblastoma: Results and outcomes of a single institution’s experience. Skull Base. 2009;19(2):133-40. DOI: 10.1055/s-0028-1096195.
  26. Hollen TR, Morris CG, Kirwan JM, Amdur RJ, Werning JW, Vaysberg M, et al. Esthesioneuroblastoma of the nasal cavity. Am J Clin Oncol. 2015;38(3):311-4. DOI: 10.1097/COC.0b013e31829b5631.
  27. Hwang SK, Paek SH, Kim DG, Jeon YK, Chi JG, Jung HW. Olfactory neuroblastomas: survival rate and prognostic factor. J Neurooncol. 2002;59(3):217-26. DOI: 10.1023/a:1019937503469.
DOI: https://doi.org/10.2478/rjr-2023-0016 | Journal eISSN: 2393-3356 | Journal ISSN: 2069-6523
Language: English
Page range: 94 - 102
Submitted on: Feb 8, 2023
Accepted on: Mar 27, 2023
Published on: Jul 26, 2023
Published by: Romanian Rhinologic Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Bianca Rusu, Daniel Lupoi, Mihai Dragomir, Carmen Badea, published by Romanian Rhinologic Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.